1. Home
  2. LODE vs SLGL Comparison

LODE vs SLGL Comparison

Compare LODE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$4.29

Market Cap

290.0M

Sector

Industrials

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$79.31

Market Cap

247.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LODE
SLGL
Founded
1999
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.0M
247.1M
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
LODE
SLGL
Price
$4.29
$79.31
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$4.00
$110.00
AVG Volume (30 Days)
1.6M
28.4K
Earning Date
05-11-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
N/A
EPS
N/A
N/A
Revenue
$1,553,796.00
N/A
Revenue This Year
$1,582.85
N/A
Revenue Next Year
$246.20
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.24
$6.96
52 Week High
$4.98
$97.97

Technical Indicators

Market Signals
Indicator
LODE
SLGL
Relative Strength Index (RSI) 56.31 51.77
Support Level $3.06 $66.85
Resistance Level $4.79 $75.00
Average True Range (ATR) 0.32 5.47
MACD -0.03 -0.11
Stochastic Oscillator 53.73 42.45

Price Performance

Historical Comparison
LODE
SLGL

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: